Albert Saporta
Chairman at Stallergenes Ibérica SA
Profile
Albert Saporta is currently the Chairman at Stallergenes Ibérica SA, the Non-Executive Chairman at ASAP France SARL, the Director at Stallergenes Italia Srl, the Director at Alergovet SA, the Director at Stallergènes Sp zoo, the Director at Stallergenes, Inc., and the President & Director at Fabentech SAS.
Previously, he served as the Chairman at Stallergenes Belgium SA from 2004 to 2012, the Chairman at Stallergenes AG, the Director at Stallergenes SA from 1999 to 2014, the Independent Director at Hybrigenics SA from 2012 to 2019, the Head-European Operations at Pasteur Merieux Serums et Vaccins SA, the Chief Investment Officer at Alternative Investment Management & Research SA, the Head-International Development at Pasteur Mérieux Connaught, and the Chief Financial Officer at Institut Mérieux SA.
Albert Saporta active positions
Companies | Position | Start |
---|---|---|
Stallergenes Ibérica SA | Chairman | 25/07/2010 |
Alergovet SA | Director/Board Member | 25/07/2010 |
Stallergènes Sp zoo | Director/Board Member | 31/12/2010 |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The private company has a deep understanding of allergens and is committed to innovation. | Director/Board Member | 31/12/2008 |
Stallergenes, Inc. | Director/Board Member | 31/12/2010 |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | President | - |
ASAP France SARL | Chairman | - |
Former positions of Albert Saporta
Companies | Position | End |
---|---|---|
ATON | Director/Board Member | 13/10/2019 |
STALLERGENES | President | 12/01/2012 |
░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ATON | Health Technology |
Private companies | 14 |
---|---|
Pasteur Merieux Serums et Vaccins SA | Health Technology |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Alternative Investment Management & Research SA
Alternative Investment Management & Research SA Alternative Investment Management & Research SA (AIM&R) is an alternative research and investment management firm which was founded in 1995 by Albert Saporta. Located in Geneva, Switzerland, AIM&R manages the S.O.G. Fund and SOGAsia hedge funds and managed accounts for sophisticated investors. In 2003 the firm formed a strategic alliance with United Overseas Bank Ltd., Singapore, through their subsidiary UOB Global Capital LLC, for the exclusive worldwide distribution of the SOGAsia Fund. AIM&R also advises hedge funds and trading groups. | |
Pasteur Mérieux Connaught | |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
Stallergenes Ibérica SA | |
Stallergenes Belgium SA
Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium. | Health Technology |
Alergovet SA | |
Stallergenes AG
Stallergenes AG Pharmaceuticals: OtherHealth Technology Stallergenes AG engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields. It specializes in the production of allergen extracts for allergen immunotherapy. The firm also offers tools for the diagnosis of allergies. The company was founded on October 28, 1996 and is headquartered in Dietlikon, Switzerland. | Health Technology |
Stallergènes Sp zoo | |
Stallergenes, Inc. | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Health Services |
ASAP France SARL | |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The private company has a deep understanding of allergens and is committed to innovation. | Distribution Services |
- Stock Market
- Insiders
- Albert Saporta